These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1811743)

  • 1. [The sterilization of ophthalmic solutions].
    Pănescu C
    Oftalmologia; 1991; 35(1):69-74. PubMed ID: 1811743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sterility testing of ophthalmic ointments using isopropyl myristate.
    Robertson JH
    Bull Parenter Drug Assoc; 1974; 28(6):288-94. PubMed ID: 4455325
    [No Abstract]   [Full Text] [Related]  

  • 3. [Compounding of ophthalmic drugs in the pharmacy. Special care must be taken!].
    Daniels R
    Pharm Unserer Zeit; 2010 Jul; 39(4):306-11. PubMed ID: 20589805
    [No Abstract]   [Full Text] [Related]  

  • 4. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.
    Bozdağ S; Gümüş K; Gümüş O; Unlü N
    Eur J Pharm Biopharm; 2008 Sep; 70(1):260-9. PubMed ID: 18590953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sterility of non-preservative eye drops.
    Prabhasawat P; Chotikavanich S; Leelaporn A
    J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S6-10. PubMed ID: 16681044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preservative agents and parameters determining their effectiveness].
    Jaminet F
    Farmaco Prat; 1970 Aug; 25(8):457-500. PubMed ID: 4990130
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antibiotic stability in magistral collyria].
    Tihărău A; Voiculescu E; Vancea S; Teodorescu A; Cherecheş S
    Oftalmologia; 1990; 34(2):97-104. PubMed ID: 2101048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study of the stability of dioxopromethazine in aqueous solutions and ophthalmic instillation].
    Capkova Z; Hudecová T; Hatrík S; Havránek E; Vitková Z
    Ceska Slov Farm; 2004 Jul; 53(4):187-91. PubMed ID: 15369230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Possibility of sterilizing eyedrops by a bacterial filtration method].
    Danilenko AA; Sokolova IP; Sipinskaia OF; Kurilenko AV
    Farmatsiia; 1978; 27(5):50-2. PubMed ID: 700186
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antimicrobial agents in eyedrops].
    Sklubalová Z
    Ceska Slov Farm; 2004 May; 53(3):107-16. PubMed ID: 15218731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ON THE PREPARATION OF OPHTHALMIC SOLUTIONS: ANTIMICROBIAL APPARATUS].
    DUBAN G
    Boll Chim Farm; 1964 Dec; 103():849-66. PubMed ID: 14261694
    [No Abstract]   [Full Text] [Related]  

  • 12. Technology of eye drops containing aloe (Aloe arborescens Mill.--Liliaceae) and eye drops containing both aloe and neomycin sulphate.
    Kodym A; Marcinkowski A; Kukuła H
    Acta Pol Pharm; 2003; 60(1):31-9. PubMed ID: 12848365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of the technology of the substance of davikol and standardization].
    Bakuridze A; Shengelia D; Kurdiani N; Mikaia G; Karanadze N
    Georgian Med News; 2008 Jan; (154):43-7. PubMed ID: 18323593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of contaminating bacteria in over-the-counter artificial tears.
    Harris MG; Gee A; Kusumoto R; Lee H
    J Am Optom Assoc; 1996 Nov; 67(11):676-80. PubMed ID: 8979661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Physical and chemical stability of fortified ophtalmic ready-to-use solutions: review of literature].
    Sourdeau P; Evrard JM; Remy G; Hecq JD
    Ann Pharm Fr; 2012 Mar; 70(2):104-12. PubMed ID: 22500962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use and sterility of multidose ophthalmic medications.
    Tamer HR; Sweet BV; Ross MB
    Am J Hosp Pharm; 1994 Feb; 51(4):500-2. PubMed ID: 8017416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacteriologic evaluation of ophthalmic methylcellulose preparations prepared at the hospital].
    Irkeç M; Yuluğ A
    Mikrobiyol Bul; 1988; 22(3):235-7. PubMed ID: 3252115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of formulation of hipromellose eye drops (artificial tears)].
    Inkeniene AM; Klimas R; Briedis V; Maciulevicius J
    Medicina (Kaunas); 2003; 39(1):77-82. PubMed ID: 12576769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A pharmacist's view on collyria (author's transl)].
    Veselý V
    Cesk Oftalmol; 1981 Sep; 37(5):365-71. PubMed ID: 7317971
    [No Abstract]   [Full Text] [Related]  

  • 20. Bacteriological control of collyria.
    Papavassiliou J; Albalas B; Zouroudis N; Chitiroglou-Lada K; Siouti M
    Pharm Acta Helv; 1977; 52(12):293-5. PubMed ID: 615315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.